Hereditary cancer: family history, diagnosis, molecular genetics, ecogenetics, and management strategies

Biochimie
Henry T Lynch, Jane F Lynch

Abstract

The translation of knowledge about hereditary breast cancer and its improved control, as well as prevention through prophylactic surgery, has been significantly accelerated through the veritable explosive discoveries in molecular genetics inclusive of BRCA1 and BRCA2 germline mutations. Needed however, among the physician community, medical geneticists, and genetic counselors, is a raised level of knowledge about hereditary breast cancer syndromes. Particular attention needs to be given to their extant genotypic and phenotypic heterogeneity, their natural history, and foremost, the requirement of a sufficiently detailed family history, with knowledge as to how to interpret its significance so that hereditary cancer syndrome can be diagnosed, should it, in fact, exist in the particular family. Collectively, surveillance and management programs can then be developed for the patient and his or her high-risk relatives. We believe very firmly that this knowledge needs to be extended to the individual patient(s), first- and second-degree relatives so that they can benefit from this knowledge.

References

Oct 1, 1979·The Journal of Urology·H T LynchJ F Lynch
Aug 9, 1976·JAMA : the Journal of the American Medical Association·H T LynchH A Guirgis
Jul 1, 1976·Journal of the National Cancer Institute·J J Mulvihill
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y MiyoshiG Petersen
Jun 1, 1992·Gut·J R Jass, S M Stewart
Jul 13, 1991·Lancet·S A NarodG M Lenoir
Aug 1, 1990·Diseases of the Colon and Rectum·M L ArvanitisE McGannon
Nov 1, 1987·Gastroenterology·J P Mecklin
Nov 1, 1987·The American Journal of Medicine·H AbusamraH H Rotmensch
Sep 1, 1987·The Journal of Dermatologic Surgery and Oncology·T H LawS A Muller
Jan 1, 1987·Seminars in Surgical Oncology
Nov 1, 1986·American Journal of Medical Genetics·L HerreraA A Sandberg
Feb 1, 1985·Cancer Genetics and Cytogenetics·H T LynchS E Markvicka
Feb 1, 1973·Surgery, Gynecology & Obstetrics·H T Lynch, A J Krush
May 1, 1974·Surgery, Gynecology & Obstetrics·H T LynchA Kaplan
Sep 1, 1974·Cancer·J UtsunomiyaT Ichikawa
Jun 1, 1971·Cancer·H T Lynch, A J Krush
Feb 1, 1966·Archives of Internal Medicine·H T LynchA J Krush
May 1, 1984·Annals of Internal Medicine·C R Boland, F J Troncale
Nov 1, 1995·Gastroenterology·D C Chung, A K Rustgi
Sep 7, 1995·The New England Journal of Medicine·E GiovannucciF E Speizer
Mar 30, 1995·The New England Journal of Medicine·S R HamiltonB Tetu
Aug 2, 1995·Journal of the National Cancer Institute·G Marra, C R Boland
Mar 18, 1994·Science·N PapadopoulosM D Adams
Mar 6, 1996·Journal of the National Cancer Institute·M S Rhyu

❮ Previous
Next ❯

Citations

Nov 12, 2003·Reproductive Biology and Endocrinology : RB&E·Alice S T Wong, Nelly Auersperg
Jan 17, 2015·Journal of Experimental & Clinical Cancer Research : CR·Karolina TeczaEwa Grzybowska
Jul 16, 2003·Oncology Nursing Forum·Nan S LeslieJennifer G Veshnesky
Apr 20, 2006·British Journal of Cancer·M KorenE Friedman
May 7, 2003·Der Internist·F Kullmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Edison T Liu
Expert Review of Molecular Diagnostics
Jean-Pierre GilletJosé Remacle
© 2022 Meta ULC. All rights reserved